1. Plasma androstenedione, plasma oestrone and the conversion of plasma androstenedione into oestrone were measured in 19 post-menopausal women without fractures (six of them oophorectomized) and 18 with vertebral or femoral neck fractures (four of them oophorectomized).
Introduction
A series of papers by Siiteri and his colleagues (MacDonald, Rombaut & Siiteri, 1967; Grodin, Siiteri & MacDonald, 1973; Hemsell, Grodin, Brenner, Siiteri & MacDonald, 1974) have shown that an essential source of oestrone in postmenopausal women is by conversion from an drostenedione (androst-4-ene-3,17-dione) peripheral tissues (probably fat cells) and have claimed that the conversion rate goes up with age, that it is a function of body weight and (by implication) is the principal determinant of the plasma oestrone concentration in post-menopausal women.
It occurred to us that low conversion rate might be a factor in post-menopausal osteoporosis and we have therefore measured plasma an drostenedione and oestrone concentrations and the androstenedione to oestrone conversion rates in a series of normal post-menopausal and fracture cases. We have found that the principal determi nant of the plasma oestrone concentration in postmenopausal women is not the conversion rate but the plasma androstenedione concentration, and that the conversion rates do not differ as between normal and fracture cases.
Clinical material and methods

Patients and materials
Studies were performed on 27 intact postmenopausal women (14 of them with vertebral or femoral neck fractures) and 10 oophorectomized women (four of them with fractures). The age range was 51-88 years.
For the conversion study [6,7- 
Method
The doses were administered intravenously and urine was collected for 72 h. After standard HC1 hydrolysis, followed by solvent extraction, the oestrogens were separated by alkaline extraction. On acidification, the liberated oestrogens were extracted with ether and subjected to chromatography either on a Celite 545 column (linear gradient elution from isooctane to ethyl acetate) (MacDonald et al., 1967; Siiteri, 1963) or on a Sephadex LH-20 column (methylene chloride/methanol, 95:5) (Olivo, Vittek, Southren, Gordon & Rani, 1973; Gupta, Attanasio & Raaf, 1975) .
Whole fractions were counted for radioactivity. The fractions containing labelled oestrone were pooled, 1 mg of carrier oestrone was added and the fractions were methylated with dimethyl sulphate to 3-methylether (Brown, 1955; Bush, 1961) or made to react with bis-trimethylsilyl acetamide to give 3-trimethylsilylether (Adessi, Eichenberger, Tran Quang, Nhuan & Jayle, 1975) . After final column chromatography on alumina in methylene chloride or chloroform respectively, the fractions containing the 3-ethers were used for purposes of calculation.
Plasma oestrone and androstenedione con centrations were measured, in fasting samples taken at 09.00 hours, by radioimmunoassay. Plasma (1 ml) was extracted with sodium-dried ether for the oestrone and 0-1 ml for the an drostenedione assay. For the oestrone assay, the extract was evaporated to dryness, and to it was added antiserum and 0-045 pmol of PHJoestrone in potassium phosphate buffer (pH 7-4). The solution was vortexed and incubated overnight at 4°C. On the following day, dextran-coated char coal was added, the tubes were centrifuged at 2000 rev./min for 10 min, the supernatant was decanted and counted for 10 min. For the androstenedione assay, the procedure was similar but 0-022 pmol of [ 3 H 4 landrostenedione was used. All measurements were performed in duplicate, the coefficient of variation being about 10%. The oestrone antibody was found not to inter-react with androstenedione, and vice versa. Radioactivity was measured by scintillation counting in a Beckmann LS-233 liquid-scintillation counter. The liquid scintillator consisted of 2,5-diphenyloxazol (PPO: 15 g) and 1,4-bis-(5-phenyloxazol-2-yl)benzene (POPOP: 500 mg) in 2-5 1 of toluene.
Calculations
Androstenedione to oestrone conversion was calculated from the formula of Hemsell, Grodin, Brenner, Siiteri & MacDonald (1974) Cl androstenedione metabolized to oestrone in 72 h. The radioactivity counting error on this calculation was less than 5%.
Results
The data are summarized in Table 1 . Most of the androstenedione to oestrone conversion rates fall within the range 1-3%, the mean value being 1-79%. The mean plasma oestrone is 0-116 nmol/1 and the mean plasma androstenedione 2-75 ηπιοΙΛ. There is no significant difference between the normal and oophorectomized women in any of the mean values of any of these variables. When the normal and fracture cases are compared, the conversion rates do not differ between the two groups, but the mean plasma oestrone and androstenedione concentrations are lower (though not significantly) in the fracture cases (Table 2) .
There is no significant correlation between plasma oestrone, plasma androstenedione or con version rate and body weight, age or years since menopause. Nor is there any correlation between the conversion rate and the androstenedione concentration, and only a weak (non-significant) one between conversion rate and plasma oestrone ( Fig. 1 ). There is a highly significant correlation between the plasma androstenedione (A) and oestrone (E) concentrations (Fig. 2) , which is not made any closer by taking the conversion rate (C) into account (Fig. 3) . The regression of plasma oestrone on the A x C product, shown in Fig. 3 , Oestrone ( has a slope of 0-84, which is not significantly different from unity, and the intercept on the oestrone axis is 0-074 nmol/1. In the 10 oophorec tomized women the correlation coefficient between conversion rate and plasma oestrone is 0-53, which, although not significant, is much higher than in the intact women (Table 3) . Moreover, in this group, the correlation between plasma an drostenedione and oestrone (r = 0·78) is also higher than in the intact women, and this cor relation is further improved by taking the conver sion rate into account ( Table 3 ). The close relationship between the A x C product and plasma E l in the oophorectomized women is shown in Fig. 4(a) . Fig. 4(b) shows the corresponding data for intact women, together with the regression line for Fig. 4(a) . It will be noted that there is a tendency for the oestrone values in the intact women to be higher relative to androstenedione than in the oophorectomized cases. 
Discussion
We are aware of the theoretical and practical objections to the calculation of hormonal interconversion rates from measurements on urinary excretory products rather than on blood, which have been clearly expressed by Tait & Horton (1966) , Kelly & Rizkallah (1973) and Rizkallah, Tovell & Kelly (1975) . The discrepancy between the two methods is particularly important in the measurement of androstenedione conversion into testosterone, which occurs largely in the liver, but perhaps less so in the conversion of an drostenedione into oestrone, which occurs mainly in the peripheral tissues. However, even in the latter case, the urine method yields conversion values almost twice as high as the blood method, which must be presumed to be closer to the truth (Grodin et al., 1973) . Unfortunately the method we have used is the only possible one at the present time, given the limitations on the administration of radioactivity to human subjects and given the specific radioactivity of the available labelled androstenedione. This method has been widely used in the last few years and may perhaps be considered to yield results that are a function of the true rate, even if the absolute values obtained are not accurate. The oestrone to androstenedione conversion rates in our post-menopausal subjects are compar able with those reported by previous workers using the urinary method (Poortman, Thyssen & Schwarz, 1973; Hemsell et al., 1974) . Our plasma androstenedione and oestrone values are also in the same range as those of other workers (Bardin & Lipsett, 1967; Abraham, Lobotsky & Lloyd, 1969; Longcope, 1971) . However, our data show that the variation in plasma oestrone concentration between post-menopausal women is mainly accounted for by variation in plasma androstenedione con centration rather than by variation in the rate at which androstenedione is being converted into oestrone. Interindividual differences in androstene dione concentration are therefore more important than differences in conversion rate in determining the oestrone concentration. The reason why this has not been noted before is probably that so few workers have measured both hormones in the same patients at the same time. We realize that better methodology might increase the apparent significance of the conversion rate value but it would not reduce the important role of the actual androstenedione concentration to which we have drawn attention. Nonetheless, it is somewhat surprising that, in the group as a whole, the conversion rate appears to have so little effect on the plasma oestrone concentration and only appears to be a significant determinant in oophorectomized women. The explanation may be that some post-menopausal women with intact ovaries still obtain a limited supply of oestrone from the ovarian stroma (Judd, Judd, Lucas & Yen, 1974) , although Longscope (1974) suggests that the post-menopausal ovary only secretes androgen. This would explain why the correlation between the plasma androstenedione and oestrone concentrations is higher in the oophorectomized cases than in the intact women, in whom there is a tendency for oestrone to be higher relative to androstenedione. This could also explain why the conversion rate is more closely related to the plasma oestrone in oophorectomized than intact women, although even in the former group plasma androstenedione is still the main determinant of plasma oestrone. However, even in this group, the regression line of plasma oestrone on the A x C product does not go through the origin, but has a positive intercept on the oestrone axis of about 0-07 nmol/1. In other words, the A x C product Oast column of Table 1 ) is always lower than the observed plasma E, concentration, sug gesting another source of oestrone. This other source may be the adrenals, which secrete signifi cant amounts of oestrone (Baird, Uno & Melby, 1969; Murakami, Yamaji & Ohsawa, 1976) , though it is perhaps surprising that the adrenal contribution to plasma oestrone should be so large.
We have been unable to confirm the correlations between age and body weight on the one hand and conversion rate on the other previously reported by Siiteri and his collagues. Both these correlations appear to us to arise from the pooling of young and old subjects in their series, the younger subjects having lower conversion rates and being lighter than the older subjects. Within their young and old series, however, we cannot detect any obvious correlation between conversion rate and body weight or age and this is compatible with our series of post-menopausal women in which no such correlations were found. We agree that the rates of Hemsell et al. (1974) suggest that older (presum ably post-menopausal) women convert an drostenedione into oestrone at a higher rate than pre-menopausal women, but we are unable to suggest the feedback loop, which might initiate this increased conversion at the time of life when it seems to be required. In fact we are not convinced that any feedback loop need be involved. The relationship between plasma oestrone and an drostenedione shown in Fig. 2 suggests that conversion rate is inversely related to plasma androstenedione, even if this is not detectable in our conversion data. The fall in androstenedione concentration after the menopause may therefore be sufficient to account for the rise in conversion rate reported by other workers (Marshall, Fearnley, Holmes & Nordin, 1976) . It is clear, however, that there is wide variation in plasma oestrone concentrations between post-menopausal women and that this is largely attributable to the variation in androstenedione concentrations, presumably reflecting differences in adrenal androstenedione production rates. Whether these in turn are due to variations in adrenal capacity or to variations in adrenocorticotrophin secretion remains to be established.
Finally, our results in the fracture cases are suggestive but no more. The mean plasma oestrone and androstenedione concentrations are lower in the fracture cases than the control subjects, but the differences are not significant. However, not all of these cases had severe osteoporosis; in some the fractures may have been traumatic. A larger and more homogeneous series is required to establish whether osteoporosis is associated with reduced plasma androstenedione and oestrone con centrations, but there is nothing in our data to suggest that it is associated with low conversion rates.
